Sean McClain

Sean McClain is a biotech innovator & entrepreneur based in Vancouver, WA. He is the founder and CEO of AbSci, a growth stage synthetic biology company focused on engineering microbes for the biomanufacturer of therapeutic proteins. Its patented SoluPro® expression platform rapidly produces complex proteins, ranging from mAbs, Fabs, enzymes, hormones and peptides, to emerging novel classes of biotherapeutics. Sean is passionate about developing technologies that can both drive down drug costs and enable the manufacture of difficult-to-produce molecules that would otherwise not make it to the market. Under his leadership AbSci has grown to 43 employees, raised more than $40M in capital, and has established partnerships with industry-leading pharmaceutical companies for the development of biomanufacturing technologies for life-saving drugs.